RBRohit Bakshi

Rohit Bakshi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rohit Bakshi has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 November 2006
      • Vol. 56  (11) , 555-6

    Local thrombolytic treatment of cerebral venous thrombosis in three paediatric patients.

    by Mohammad Wasay, Rohit Bakshi, Alper Dai, Steve Roach

    There is increasing evidence that local thrombolysis can be used with relative safety and efficacy in adults with superior sagittal sinus thrombosis (SSST). However, little data is available on the use of local thrombolysis in children with SSST. We report three patients who received local thrombolysis for dural sinus thrombosis. Two patients received urokinase and one patient received urokinase followed by local TPA infusion. Recanalization was achieved in two patients.


    • 19 June 2004
      • Vol. 25  (6) , 985-996

    Whole-Brain Atrophy in Multiple Sclerosis Measured by Automated versus Semiautomated MR Imaging Segmentation

    by Jitendra Sharma, Michael P. Sanfilipo, Ralph H. B. Benedict, Bianca Weinstock-Guttman, Frederick E. Munschauer, Rohit Bakshi

    BACKGROUND AND PURPOSE: Semiautomated and automated methods are used to measure whole-brain atrophy in multiple sclerosis (MS), but their comparative reliability, sensitivity, and validity are unknown.


    • 1 February 2004
      • Vol. 25  (2) , 270-273

    MR Imaging in Toxoplasmosis Encephalitis after Bone Marrow Transplantation: Paucity of Enhancement despite Fulminant Disease

    by Catalina Ionita, Mohammed Wasay, Lucia Balos, Rohit Bakshi

    Summary: We present a patient who underwent bone marrow transplantation (BMT) after developing chronic myelocytic leukemia. Four months after BMT, he became comatose and died. MR imaging revealed multifocal brain lesions that were progressive but produced no edema. Postcontrast studies revealed that most of the lesions were nonenhancing. There was only discrete, irregular leptomeningeal enhancement with possible minimal enhancement of the cortex and subcortical white matter. Autopsy showed overwhelming toxoplasmosis encephalitis. This case illustrates that toxoplasmosis lesions may lack obvious contrast enhancement in the brain of the immunocompromised patients, despite severe involvement. Recognition of this unusual MR imaging manifestation of toxoplasmosis should lead to earlier diagnosis and treatment.


  • Neuroimaging of HIV and AIDS related illnesses: a review

    by Rohit Bakshi

    Neuroimaging technology continues to unfold in a very exciting way, providing almost limitless information about the structural and functional integrity of the nervous system. In patients with an immunocompromised state such as those infected with human immunodeficiency virus (HIV) and subsequently developing acquired immunodeficiency syndrome (AIDS), neurologic complications represent an important manifestation requiring vigilance. Many of the central nervous system (CNS) disorders related to HIV and AIDS are treatable and without prompt diagnosis and treatment, will lead to significant morbidity or death. Neuroimaging plays an increasingly pivotal role in the early diagnosis and longitudinal monitoring of these conditions. The author intends to provide an overview of neuroimaging technology and its applications including various magnetic resonance imaging (MRI) and functional imaging techniques in the evaluation of patients with HIV and AIDS related CNS disorders. The role of neuroimaging in this population includes early detection of direct HIV infection, opportunistic infections, neoplasia, or cerebrovascular diseases. In addition, through a wide breadth of imaging techniques, the pathology, neurochemistry and metabolism of lesions can be studied to clarify the differential diagnosis, such as discriminating infection vs. neoplasia.


  • Thalamic Involvement in Multiple Sclerosis: A Diffusion-Weighted Magnetic Resonance Imaging Study

    by Andrew J. Fabiano, Jitendra Sharma, Bianca Weinstock-Guttman, Frederick E. Munschauer, Ralph H. B. Benedict, Robert Zivadinov, Rohit Bakshi, Frederick E. Munschauer Iii

    Background and Purpose. Injury to deep gray matter structures in multiple sclerosis (MS) has been suggested by recent neuroimaging and neuropathology studies. Diffusion‐weighted magnetic resonance imaging (MRI) can assess tissue damage with greater sensitivity than conventional MRI. The authors'objective was to assess thalamic gray matter damage by diffusion‐weighted imaging in MS patients. Methods. This was a retrospective study performed at a tertiary care, university‐affiliated comprehensive MS center of 82 MS patients and 43 controls. The main outcome measures were thalamic apparent diffusion coefficients (ADCs), whole‐brain atrophy (brain parenchymal fraction), fluid‐attenuated inversion recovery (FLAIR) hyperintense lesion volume, and clinical course. Results. ADCs in the left thalamus were higher in MS patients (0.741 ± 0.044 × 10−3 mm2/s) than controls (0.723 ± 0.036 × 10−3 mm2/s) (P= .027) and higher in secondary progressive MS patients (0.761 ± 0.044 × 10−3 mm2/s) than relapsing‐remitting MS patients (0.735 ± 0.032 × 10−3 mm2/s) (P= .029). ADCs in the right thalamus were higher in secondary progressive MS patients (0.784 ± 0.069 × 10−3 mm2/s) than controls (0.757 ± 0.038 × 10−3 mm2/s) (P= .033). In the MS group, left thalamus ADCs correlated negatively with brain parenchymal fraction (r= ‐0.30, P= .008), total left hemispheric FLAIR lesion volume correlated with ADCs in the left (r= 0.35, P= .001) and right (r= 0.39, P < .001) thalami, and total right hemispheric FLAIR lesion volume correlated with ADCs in the left (r= 0.31, P= .006) and right thalami (r= 0.22, P= .048). Conclusion. MS patients have increased water diffusion in the thalamus that is partly associated with clinical course, lesion load, and whole‐brain atrophy. Both indirect and direct mechanisms of gray matter injury may play a role in the pathophysiology of MS.


    • 1 July 2003
      • Vol. 13  (3) , 215-7

    Neuroimaging curriculum for neurology trainees: report from the Neuroimaging Section of the AAN.

    by Rohit Bakshi, Andrei V Alexandrov, Camilo R Gomez, Joseph C Masdeu

    Neuroimaging plays a major role in the evaluation of patients with neurological disorders. Surveys of neurologists have revealed that most rely on their own readings of images for patient management, and a majority believe that neurologists should be allowed to officially interpret and bill for scan reviews. The importance of neuroimaging training for neurology residents has been stressed by the Association of University Professors of Neurology. Although there is a desire to promote the neuroimaging education of neurologists, no curricula have existed previously. The Neuroimaging Section of the American Academy of Neurology (AAN) developed a task force of practicing neuroimagers to provide a neuroimaging curriculum for neurological trainees and training directors. The resulting curriculum is available on the Web sites of the AAN (http://www.aan.com) and the American Society of Neuroimaging (http://www.asnweb.org/education/curriculum.shtml) and will be updated as the need arises through evolving technology or breadth of applications. This curriculum should help in the design of neurology residency and fellowship programs and subspecialty pathways in which adequate neuroimaging education and training are desired for various reasons, including certification and the demonstration of competency and proficiency.


    • 1 July 2003
      • Vol. 13  (3) , 240-7

    Brain CT and MRI findings in 100 consecutive patients with intracranial tuberculoma.

    by Mohammad Wasay, Bhojo A Kheleani, Mahesh K Moolani, Jazia Zaheer, Margaret Pui, Sheema Hasan, Suhail Muzaffar, Rohit Bakshi, Arif R Sarawari

    The characteristics of intracranial tuberculoma on computed tomography (CT) and magnetic resonance imaging (MRI) are not well known. The authors reviewed the features of tuberculoma on CT scans and MRI. The authors also correlated the MRI characteristics on various pulse sequences with neuropathological findings. The charts of patients with intracranial tuberculoma were consecutively reviewed during the period from 1988 to 1999. The diagnosis of tuberculoma was based on pathology (n = 19), clinical or neuroimaging response to tuberculous chemotherapy (n = 57), or evidence of systemic tuberculosis (n = 24). Neuropathological specimens of tuberculoma were graded for the amount of fibrosis, gliosis, necrosis, and cell types (lymphocytes, macrophages, plasma cells). One hundred patients (43 men) were identified. The age range was 1 to 75 years (mean = 30 y). The number of lesions ranged from 1 to > 100 (mean = 4.5 lesions/patient). Thirty-one patients had solitary lesions, whereas 69 had multiple lesions. Thirty-seven patients had hydrocephalus. After contrast administration, > 450 lesions were seen on CT and MRI images in all 100 scans. The diameter of these enhancing lesions ranged from 1 mm to 5 cm. Lesions > 1 cm showed varied enhancement, including irregular shapes, ringlike shapes, open rings, and lobular patterns. Targetlike lesions were seen in only 2 patients. Other features included cortical and subcortical infarcts (12 patients), calcification (10% of lesions), edema (33 patients), meningeal enhancement (12 patients), mass effect, and/or midline shift (18 patients). A hypointense core with a hyperintense rim was the most common signal characteristic on T2-weighted MRI. The central hypointensity on T2-weighted and fluid-attenuated inversion recovery (FLAIR) images reflected extensive necrosis and hypercellularity. Multiple tuberculomas and infratentorial locations were more common in the authors' patient population than in previous reports. The MRI signal characteristics of intracranial tuberculoma are extremely diverse. An isointense or hypointense core with a hyperintense rim on T2-weighted and FLAIR images is the most common presentation. Core hypointensity of lesions on these images is related to necrosis and the large number of cells.


  • Neuroimaging Curriculum for Neurology Trainees: Report from the Neuroimaging Section of the AAN

    by Rohit Bakshi, Andrei V. Alexandrov, Camilo R. Gomez, Joseph C. Masdeu


  • Fatigue associated with multiple sclerosis: diagnosis, impact and management

    by Rohit Bakshi

    In patients with multiple sclerosis (MS) fatigue is the most common symptom and one of the most disabling features. A s many as 40% have described it as the single most disabling symptom - a higher percentage than weakness, spasticity, motor problems, or bowel or bladder problems. The etiology and patho physiology of MS-related fatigue remain unknown. Studies have failed to demonstrate an association between MS-related fatigue and the level of disability, clinical disease subtype, or gender, although recent data show an association between MS-related fatigue and depression and quality of life. Imaging studies using positron emission tomography suggest that fatigue in MS is related to hypometabolism of specific brain areas, including the frontal and subcortical circuits. The impact of fatigue on patient functioning and quality of life clearly warrants intervention. In addition to nonpharmacologic measures, such as exercise and energy conservation strategies, several pharmacologic agents have been evaluated for their ability to reduce MS-related fatigue, including amantadine, central nervous system stimulants (pemoline), and the novel wake-promoting agent modafinil.